![[TXT]](/icons/text.gif) 121b.1012-Does cIMT regression predict reduction of CV events. MA of 41 RCTs_Costanzo, jacc.pdf | 413.91Kb | December 6 2010 |
| 124.1012-Predicting the risk of CHD. 1 The use of conventional risk markers_Dent, AthS.pdf | 142.28Kb | December 6 2010 |
| 124.1012-Predicting the risk of CHD. 2 Role of novel molecular biomarkers and genetics ._._Dent, AthS.pdf | 178.92Kb | December 6 2010 |
| 130.1011-FR cardiovasc et Prévention_Simon, RevPrat.pdf | 272.45Kb | December 6 2010 |
| 135.1012-BMI and mortality among 1.146 million white adults_de Gonzales, nejm.pdf | 473.44Kb | December 6 2010 |
| 212.1012-Age- and gender-specific prevalence of CV-RF in 40.102 patients with 1st ever IS_Andersen, Stroke.pdf | 323.69Kb | December 6 2010 |
| 234.1012-Metabolic syndrome and Cerebral vasomotor reactivity_Giannopoulos, Eur J Neurol.pdf | 96.02Kb | December 6 2010 |
| 241.1012-CAS characterisation with CE-US imaging and its histological validation_Molinari, JVU.pdf | 2.92Mb | December 6 2010 |
| 252.1012-Predicting risk of peri-op death and stroke after CEA in ASx patients. Clinical risk score_Calvillo-King, Stroke.pdf | 314.68Kb | December 6 2010 |
| 255.1012-1 CAST vs CEA, New results in perspective_Perkins, Mayo Clin Proceed.pdf | 827.83Kb | December 6 2010 |
| 255.1012-2 Management of CAS, CEA or CAST_Adams, Mayo Clin Proceed.pdf | 535.99Kb | December 6 2010 |
| 257.1011ep-Benign outcome of objectively proven spontaneous recanalization of ICA occlusion. Long-term FU_Camporese, jvs.pdf | 396.50Kb | December 6 2010 |
| 265.1012-Carotid artery pseudoaneurysm_Ayoub, JVU.pdf | 1.66Mb | December 6 2010 |
| 274.1012-Is CAD responsible for perioperative strokes after CABG-Trans-Atlantic debate, ejves.pdf | 156.87Kb | December 6 2010 |
| 278.1012-Ulcerated plaques in the aortic arch contribute to Sx multiple brain infarction_Yoshimura, jnnp.pdf | 172.50Kb | December 6 2010 |
| 314.1012-PAOD. Evaluation of a high spatial & temporal 3T MR protocol with low total dose of Gadolinium_Attenberger, Radiology.pdf | 1.33Mb | December 6 2010 |
| 321d.1011ep-Use and Utility of ABI in patients with diabetes_Potier, ejves.pdf | 231.67Kb | December 6 2010 |
| 332.1012-Aspirin for Iary prevention of CV events in patients with PAD or T2 diabetes_Soejima, TH.pdf | 70.64Kb | December 6 2010 |
| 333.1011-Stenting de l'AFS et CRPus. Etude multicentrique SAFE_Beregi, Press Med.pdf | 309.83Kb | December 6 2010 |
| 371.1012-Plasma D-Dimer and AAA_Takagi, Thromb Res.pdf | 395.56Kb | December 6 2010 |
| 377.1012-Early AAA endografts. A decade FU results_Mestres, ejves.pdf | 502.17Kb | December 6 2010 |
| 418.1011-Managing frostbite. Clinical review_Hallam, bmj.pdf | 414.96Kb | December 6 2010 |
| 422.1012-Combined thrombophilic factors increase the risk of recurrent TE in Behcet's disease_Yasar, Clin Rheumatol.pdf | 181.10Kb | December 6 2010 |
| 55.1011-Evaluation des ex. compl. ds la démarche Dg. Utiles et Inutiles_François, RevPrat.pdf | 174.58Kb | December 6 2010 |
| 58.1011-Lecture critique d'article rapportant l'évaluation d'une procédure Dg_François, RevPrat.pdf | 110.59Kb | December 6 2010 |
| 615.1012-Physical activity and risk of VTE. ThromsO study_Borch, Haematologica.pdf | 678.61Kb | December 6 2010 |
| 620.1012-Eradication of hospital-acquired VTE_Goldhaber, TH.pdf | 94.48Kb | December 6 2010 |
| 620.1012-Improve the results of phase 2 trials of thromboprophylaxis with the new oral anticoagulant drugs_Zufferey, TH.pdf | 58.12Kb | December 6 2010 |
| 632b.1012-The inter-rater reliability of the PESI_Fraga, TH.pdf | 74.02Kb | December 6 2010 |
| 633b.1012-Combined risk stratification with CTA-EchoC and biomarkers in patients with normotensive PE_Ozsu, Thromb Res.pdf | 478.47Kb | December 6 2010 |
![[DIR]](/icons/back.gif){kind=icon}
Parent Directory